Meridian Bioscience, Inc. (NASDAQ:VIVO)

CAPS Rating: 5 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

Results 1 - 20 of 59 : 1 2 3 Next »

Recs

0
Member Avatar diablo138 (47.07) Submitted: 1/13/2014 4:51:03 PM : Outperform Start Price: $26.71 VIVO Score: -21.64

Bio baby, this stock has great momentum!

Recs

0
Member Avatar mackfack (91.01) Submitted: 10/25/2012 4:04:11 PM : Outperform Start Price: $12.64 VIVO Score: +19.38

Coming out of a trough that lasted 2-3 years. New platforms and realigned resources are ready to run...

Recs

0
Member Avatar TempoAllegro (47.03) Submitted: 9/12/2012 9:57:29 AM : Outperform Start Price: $17.30 VIVO Score: -4.89

VIVO makes a range of diagnostic tests for foodborne, parasitic, viral, and other diseases that you can do at home. The kits are now available in North America, Europe, Africa, and the Middle East.

With increasing threats to the food supply and environmental concerns such as lack of proper water for both humans and livestock, these tests will be both helpful and in greater demand in coming years.

Add to that its great balance sheet - currently with zero debt and current ratio of over 5, plus high insider ownership, generous dividend, and 5-year projected growth in the mid-teens, and we have an excellent addition to anyone's health-oriented portfolio.

Recs

0
Member Avatar BrodieMan720 (95.77) Submitted: 9/19/2010 5:20:13 PM : Outperform Start Price: $18.47 VIVO Score: -48.40

Very solid looking company. Nice quick ratio and strong returns make it very appealing. Decent dividend, too. Not really sure of what sort of things they have in the pipeline, but their core business seems to be doing well. Very nice growth rates top it off.

Recs

0
Member Avatar benbanner (86.03) Submitted: 8/19/2010 1:14:23 PM : Outperform Start Price: $16.54 VIVO Score: -42.50

Good fundamentals...no LT debt, div paying stock.

Recs

0
Member Avatar jrwatkins2008 (82.06) Submitted: 5/8/2010 9:38:24 PM : Outperform Start Price: $16.65 VIVO Score: -31.61

No debt a lot of cash high yield won't go down as much over the next 2-3 months and will come back strong

Recs

0
Member Avatar jamesm113 (< 20) Submitted: 3/22/2010 3:21:28 PM : Outperform Start Price: $18.04 VIVO Score: -40.17

h1n1 or some other virus will be back. long term buy.

Recs

0
Member Avatar TraderHater (45.99) Submitted: 3/17/2010 6:27:42 PM : Outperform Start Price: $17.10 VIVO Score: -33.20

There's always next season's pandemic to consider, long term buy

Recs

0
Member Avatar geomanpa (< 20) Submitted: 8/24/2009 9:59:51 PM : Outperform Start Price: $20.37 VIVO Score: -75.17

Awesome management

Recs

0
Member Avatar vgaymer (< 20) Submitted: 4/12/2009 4:55:58 PM : Outperform Start Price: $14.70 VIVO Score: -75.03

msn screen:

5 year div. growth >= 20 %
annual eps growth >= 25%
debt/eq <= 0.5
current dividend >= 2.5%

Recs

0
Member Avatar Money4e (60.39) Submitted: 3/20/2009 7:47:01 AM : Outperform Start Price: $14.71 VIVO Score: -92.33

Rapid testing products for medical conditions. Help keep malpractice rates down and is becoming cheaper. Get's the patient tested for certain illnesses quickly which means earlier treatment, which means cheaper for the medical company

Recs

2
Member Avatar DODEA (57.51) Submitted: 12/29/2008 11:53:02 AM : Outperform Start Price: $12.98 VIVO Score: +26.08

Meridian Biosciences has been a great pick for me since 1989. It was one of the very first stocks I owned, and my second DRIP. It has very strong financials, an intelligent business plan, and many products in its pipeline. This is an excellent small-cap stock for getting in on the ground floor.

Recs

0
Member Avatar WilliamCrook2007 (< 20) Submitted: 11/20/2008 2:47:04 PM : Outperform Start Price: $19.13 VIVO Score: -128.84

ibd

Recs

0
Member Avatar moof77 (58.39) Submitted: 11/11/2008 3:22:24 AM : Outperform Start Price: $19.11 VIVO Score: -97.32

Well managed company whose products will only see more demand in coming years.

Recs

0
Member Avatar CKENNED2 (< 20) Submitted: 9/24/2008 11:20:43 PM : Outperform Start Price: $23.38 VIVO Score: -67.61

MERIDIAN IS POISED TO GAIN NEW BUSINESS UNFORTOLD

Recs

0
Member Avatar diva27 (39.54) Submitted: 9/17/2008 9:19:31 AM : Outperform Start Price: $22.23 VIVO Score: -63.54

Vivo's services are always going to be necessary, the world is not exactly getting healthier and healthier. They presently have good numbers and have shown some growth in the past. I'm confident that this is one of those stocks to watch.

Recs

0
Member Avatar hiBo (95.49) Submitted: 6/16/2008 12:51:01 AM : Outperform Start Price: $25.02 VIVO Score: -55.52

excellent financials. high percentage of insider ownership

Recs

1
Member Avatar healthcareinvest (51.40) Submitted: 5/5/2008 1:42:30 PM : Outperform Start Price: $22.80 VIVO Score: -42.75

Most robust point of care testing portfolio- growth not likely to slow much given the diverse lab tests available- life science sector should improve over time.

Recs

0
Member Avatar viclyn509 (20.85) Submitted: 4/24/2008 6:46:17 PM : Outperform Start Price: $22.35 VIVO Score: -42.04

No debt-Large cash flow -bright future

Recs

0
Member Avatar capsterok (70.70) Submitted: 4/24/2008 6:09:06 PM : Outperform Start Price: $27.67 VIVO Score: -66.62

Testing out a portfolio of smallish-cap 5-star stocks found using the CAPS screener. All picks have at least 50 allstars backing them, which should be enough to minimize star rating fluctuations. It's only been about a week, and I expect a LOT of volatility, but I have high hopes for market beating performance. Time will tell...

Results 1 - 20 of 59 : 1 2 3 Next »

Featured Broker Partners


Advertisement